Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Renovaro Biosciences to Combine with GEDi Cube to Accelerate Personalised Medicine for Longevity.

Document Cited in Related
Vincent

MANews-(C)2009-2023

US-based preclinical biotechnology firm Renovaro Biosciences Inc. (NASDAQ: RENB) has agreed to combine with Netherlands-based AI medical technology company GEDi Cube Intl Ltd., the company said.

The Transaction is structured as a stock-for-stock acquisition whereby all of GEDi Cube's outstanding equity interests will be exchanged for shares of Renovaro common stock.

Following the closing of the Transaction, GEDi Cube equity holders are expected to own approximately 50% of the combined company, subject to certain adjustments provided for in the definitive agreement.

The agreement was executed by a supermajority controlling interest of 78 % of GEDi Cube shareholders; it is expected the remaining 22 % will be included in the agreement prior to closing.

GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.

If completed, the Transaction will result in a combined company...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT